Alkermes Inc. plc
$49.18
USD
Last updated on --.
24h volume435.72K
24h highest49.8840 USD
24h lowest48.3990 USD
24h Price movement+1.68%


ALKS recent prices
24 Hours
+1.68%+$0.812
30 days
-10.83%-$5.880
60 days
+14.04%+$5.960
90 days
+41.81%+$14.63
Key data
Previous close48.3700 USD
Market cap8.79B USD
Volume435.72K
P/E ratio122.720000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.39000 USD
Net income (FY)66.12M USD
Revenue (FY)1.67B USD
Last report dateJul 28, 2026
About Alkermes Inc. plc
HeadquartersDUBLIN 4
Employees (FY)2.05K
Revenue per employee (FY)813.49K USD
Net income per employee (FY)32.26K USD
Listed onNasdaq
ALKS conversion tables
| 0.5 ALKS | 24.59 USD |
| 1 ALKS | 49.18 USD |
| 5 ALKS | 245.91 USD |
| 10 ALKS | 491.82 USD |
| 0.5 USD | 0.010166 ALKS |
| 1 USD | 0.020333 ALKS |
| 5 USD | 0.10166 ALKS |
| 10 USD | 0.20333 ALKS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ALKS is trading at $49.18, +1.68% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ALKS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ALKS is currently trading at $49.18, +1.68% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ALKS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ALKS's P/E ratio is currently 122.720000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ALKS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ALKS's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Alkermes Inc. plc's market cap is currently 8.79B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume435.72K
24h highest49.8840 USD
24h lowest48.3990 USD
24h Price movement+1.68%


Start trade with ALKS Perpetual
Sign up to trade












